RICHMOND, Va. and RENO, Nev., Jan. 26, 2026 /PRNewswire/ -- Alps Dx and Hamilton Company today announced the showcase of...
VANCOUVER, British Columbia, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company”...
Independent report examines Calm Nature CBD Gummies full spectrum formulation, CO2 extraction claims, THC removal disclosures, third-party COA availability, and...
RICHMOND, Va., Jan. 7, 2026 /PRNewswire/ -- Alps Dx today announced its official launch as an innovative diagnostics tooling and...
RICHMOND, Va., Jan. 7, 2026 /PRNewswire/ -- Alps Dx today announced its official launch as an innovative diagnostics tooling and...
RICHMOND, Va., Jan. 7, 2026 /PRNewswire/ -- Alps Dx today announced its official launch as an innovative diagnostics tooling and...
Logan Jenner, a five-year-old battling acute myeloid leukemia, found new hope through a clinical trial that used Functional Precision Medicine...
As January 2026 wellness searches peak, this consumer education analysis examines how informed buyers evaluate CBD gummies for sleep and...
36-Year Company's Oral Capsule Format vs. Injectable BPC-157: Third-Party Lab Testing, Bioavailability Questions, and Regulatory Status ExaminedCARPINTERIA, Dec. 23, 2025...
Companies to leverage and collaborate on research and development, distribution, and regulatory expertise to accelerate global adoption of intelligent testing...
Companies to leverage and collaborate on research and development, distribution, and regulatory expertise to accelerate global adoption of intelligent testing...
Pluristyx to lead a new public-private consortium with 9 other industry leaders to establish global standards for non-animal drug testing...
Pluristyx to lead a new public-private consortium with 9 other industry leaders to establish global standards for non-animal drug testing...
In this free webinar, learn how modeling the tumor microenvironment in vitro supports next-generation cancer research and drug discovery. Attendees...
NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical...
Jim Foote, CEO of First Ascent Biomedical, is revolutionizing cancer care with an AI-driven, functional precision medicine platform. Inspired by...
The Company is initiating clinical studies to further validate Intelligent Fingerprinting Drug Screening System INBS anticipates FDA 510(k) clearance in...
BOSTON, Sept. 16, 2025 /PRNewswire/ -- Q2i today announced a collaboration with King's College London (King's) to evaluate its AI-powered...
LOS ANGELES, CALIFORNIA / ACCESS Newswire / September 9, 2025 / Haven House Sober Living has been nominated for Best...
Partnership delivers tamper-evident, high-integrity testing data aligned with U.S. Drug Policy Priorities WASHINGTON, Aug. 25, 2025 /PRNewswire/ -- Neopharma Technologies...